Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
PLoS One. 2013 Jun 10;8(6):e65728. doi: 10.1371/journal.pone.0065728. Print 2013.
Lipopolysaccharide (LPS) in high doses inhibits placental multidrug resistance P-glycoprotein (P-gp--Abcb1a/b) and breast cancer resistance protein (BCRP--Abcg2). This potentially impairs fetal protection against harmful factors in the maternal circulation. However, it is unknown whether LPS exposure, at doses that mimic sub-lethal clinical infection, alters placental multidrug resistance. We hypothesized that sub-lethal (fetal) LPS exposure reduces placental P-gp activity. Acute LPS (n = 19;150 µg/kg; ip) or vehicle (n = 19) were given to C57BL/6 mice at E15.5 and E17.5. Placentas and fetal-units were collected 4 and 24 h following injection. Chronic LPS (n = 6; 5 µg/kg/day; ip) or vehicle (n = 5) were administered from E11.5-15.5 and tissues were collected 4 h after final treatment. P-gp activity was assessed by [³H]digoxin accumulation. Placental Abcb1a/b, Abcg2, interleukin-6 (Il-6), Tnf-α, Il-10 and toll-like receptor-4 (Tlr-4) mRNA were measured by qPCR. Maternal plasma IL-6 was determined. At E15.5, maternal IL-6 was elevated 4 h after single (p<0.001) and chronic (p<0.05) LPS, but levels had returned to baseline by 24 h. Placental Il-6 mRNA was also increased after acute and chronic LPS treatments (p<0.05), whereas Abcb1a/b and Abcg2 mRNA were unaffected. However, fetal [³H]digoxin accumulation was increased (p<0.05) 4 h after acute LPS, and maternal [³H]digoxin myocardial accumulation was increased (p<0.05) in mice exposed to chronic LPS treatments. There was a negative correlation between fetal [³H]digoxin accumulation and placental size (p<0.0001). Acute and chronic sub-lethal LPS exposure resulted in a robust inflammatory response in the maternal systemic circulation and placenta. Acute infection decreased placental P-gp activity in a time- and gestational age-dependent manner. Chronic LPS decreased P-gp activity in the maternal myocardium and there was a trend for fetuses with smaller placentas to accumulate more P-gp substrate than their larger counterparts. Collectively, we demonstrate that acute sub-lethal LPS exposure during pregnancy impairs fetal protection against potentially harmful xenobiotics in the maternal circulation.
脂多糖(LPS)在高剂量下抑制胎盘多药耐药 P 糖蛋白(P-gp-ABCB1A/B)和乳腺癌耐药蛋白(BCRP-ABCG2)。这可能会损害胎儿对母体循环中有害因素的保护。然而,目前尚不清楚亚致死(胎儿)LPS 暴露是否会改变胎盘多药耐药性。我们假设亚致死(胎儿)LPS 暴露会降低胎盘 P-gp 活性。急性 LPS(n=19;150μg/kg;ip)或载体(n=19)在 E15.5 和 E17.5 时给予 C57BL/6 小鼠。注射后 4 和 24 小时收集胎盘和胎儿单位。慢性 LPS(n=6;5μg/kg/天;ip)或载体(n=5)从 E11.5-15.5 给予,并在最后一次治疗后 4 小时收集组织。通过[³H]地高辛积累评估 P-gp 活性。通过 qPCR 测量胎盘 Abcb1a/b、Abcg2、白细胞介素 6(IL-6)、Tnf-α、IL-10 和 toll 样受体 4(Tlr-4)mRNA。测定母体血浆 IL-6。在 E15.5 时,单次(p<0.001)和慢性(p<0.05)LPS 后 4 小时母体内 IL-6 升高,但 24 小时后恢复到基线。急性和慢性 LPS 处理后胎盘 Il-6 mRNA 也增加(p<0.05),而 Abcb1a/b 和 Abcg2 mRNA 不受影响。然而,急性 LPS 后 4 小时胎儿[³H]地高辛积累增加(p<0.05),并且在接受慢性 LPS 处理的小鼠中,母体[³H]地高辛心肌积累增加(p<0.05)。胎儿[³H]地高辛积累与胎盘大小呈负相关(p<0.0001)。急性和慢性亚致死 LPS 暴露导致母体全身循环和胎盘产生强烈的炎症反应。急性感染以时间和胎龄依赖的方式降低胎盘 P-gp 活性。慢性 LPS 降低母体心肌中的 P-gp 活性,并且胎盘较小的胎儿比其较大的胎儿更倾向于积累更多的 P-gp 底物。总之,我们证明妊娠期间急性亚致死 LPS 暴露会损害胎儿对母体循环中潜在有害物质的保护。